IRIS
MARAFINI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.345
AS - Asia 2.806
EU - Europa 1.757
SA - Sud America 375
AF - Africa 38
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 4
Totale 18.333
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.260
SG - Singapore 1.547
CN - Cina 502
IT - Italia 377
BR - Brasile 311
HK - Hong Kong 283
RU - Federazione Russa 280
DE - Germania 198
FI - Finlandia 187
IE - Irlanda 179
VN - Vietnam 159
UA - Ucraina 120
GB - Regno Unito 108
FR - Francia 94
JP - Giappone 73
KR - Corea 48
CA - Canada 45
SE - Svezia 45
PL - Polonia 43
IN - India 39
NL - Olanda 32
BD - Bangladesh 23
MX - Messico 23
ID - Indonesia 21
AT - Austria 20
IQ - Iraq 20
AR - Argentina 19
ES - Italia 18
TR - Turchia 16
EC - Ecuador 13
BE - Belgio 12
ZA - Sudafrica 12
CL - Cile 11
LT - Lituania 11
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CO - Colombia 7
MA - Marocco 7
MY - Malesia 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
IL - Israele 5
IR - Iran 5
JO - Giordania 5
PH - Filippine 5
TN - Tunisia 5
A1 - Anonimo 4
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
GR - Grecia 4
JM - Giamaica 4
PK - Pakistan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CZ - Repubblica Ceca 3
ET - Etiopia 3
EU - Europa 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
NO - Norvegia 3
NP - Nepal 3
RO - Romania 3
VE - Venezuela 3
AM - Armenia 2
BO - Bolivia 2
CR - Costa Rica 2
KE - Kenya 2
LK - Sri Lanka 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
TW - Taiwan 1
VG - Isole Vergini Britanniche 1
Totale 18.333
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.135
Wilmington 2.922
Houston 2.765
Singapore 720
Fairfield 524
Ashburn 435
Ann Arbor 295
Hong Kong 281
San Jose 279
Chandler 268
Seattle 229
Beijing 183
Cambridge 180
Rome 153
Dublin 152
Council Bluffs 150
Helsinki 146
Medford 123
Santa Clara 108
Jacksonville 96
Los Angeles 96
The Dalles 94
Dearborn 83
New York 73
Tokyo 67
Lawrence 56
Lauterbourg 52
Chicago 51
Ho Chi Minh City 49
Buffalo 45
Moscow 38
Milan 37
Dallas 35
Hanoi 35
San Diego 35
Zhengzhou 32
Nuremberg 26
São Paulo 24
Menlo Park 23
North Bergen 23
Indianapolis 21
Kraków 21
London 20
Toronto 19
Warsaw 19
Rio de Janeiro 18
Colorado Springs 17
Munich 17
Redondo Beach 17
Shanghai 17
Atlanta 16
Chennai 16
Denver 14
Seoul 14
Brooklyn 13
Frankfurt am Main 13
Jakarta 13
Orem 13
Baghdad 12
Brussels 12
San Francisco 12
Lappeenranta 11
Montreal 11
Phoenix 11
Groningen 10
Norwalk 10
Redwood City 10
Bologna 9
Stockholm 9
Vienna 9
Columbus 8
Curitiba 8
Da Nang 8
Johannesburg 8
Miami 8
Tashkent 8
Amsterdam 7
Belo Horizonte 7
Del Norte 7
Kunming 7
Mountain View 7
Ankara 6
Boardman 6
Boston 6
Chittagong 6
City of London 6
Hải Dương 6
Mexico City 6
Naples 6
Salt Lake City 6
Verona 6
Chengdu 5
Dhaka 5
Guarulhos 5
Hangzhou 5
Kuala Lumpur 5
Madrid 5
Manchester 5
Mumbai 5
Orlando 5
Totale 14.730
Salva come PNG Salva come JPEG
Nome #
Pyoderma gangrenosum in refractory celiac disease: a case report 611
Frequency and cause of persistent symptoms in celiac disease patients on a long-term gluten-free diet 515
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 506
Interleukin-34 sustains inflammatory pathways in the gut 503
TNF-α producing innate lymphoid cells (ILCs) are increased in active celiac disease and contribute to promote intestinal atrophy in mice 485
High Smad7 sustains inflammatory cytokine response in refractory coeliac disease 477
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 475
The dual role of Smad7 in the control of cancer growth and metastasis 475
Smad7 knockdown restores aryl hydrocarbon receptor-mediated protective signals in the gut 471
Analysis of the cytokine profile in the duodenal mucosa of refractory coeliac disease patients 461
An overview of the role of innate lymphoid cells in gut infections and inflammation 459
Celiac disease-related inflammation is marked by reduction of Nkp44/Nkp46-double positive natural killer cells 459
Serum regenerating islet-derived 3-alpha is a biomarker of mucosal enteropathies 454
Sampling of proximal and distal duodenal biopsies in the diagnosis and monitoring of celiac disease 451
Interleukin-34 induces Cc-chemokine ligand 20 in gut epithelial cells 451
Antisense approach to inflammatory bowel disease: Prospects and challenges 450
CCL20 Is Negatively Regulated by TGF-β1 in Intestinal Epithelial Cells and Reduced in Crohn's Disease Patients With a Successful Response to Mongersen, a Smad7 Antisense Oligonucleotide 449
Aryl hydrocarbon receptor-driven signals inhibit collagen synthesis in the gut 448
null 442
Defective expression of scavenger receptors in celiac disease mucosa 437
Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities 425
The IL-12/23/STAT Axis as a Therapeutic Target in Inflammatory Bowel Disease: Mechanisms and Evidence in Man 408
TGF-Beta signaling manipulation as potential therapy for IBD 405
The TGF-β/Smad System in IBD Pathogenesis 403
Targeting integrins and adhesion molecules to combat inflammatory bowel disease 388
Smad7 positively regulates keratinocyte proliferation in psoriasis 379
The Food Additive Maltodextrin Promotes Endoplasmic Reticulum Stress–Driven Mucus Depletion and Exacerbates Intestinal Inflammation 373
Th17 cytokines in inflammatory bowel diseases: discerning the good from the bad 370
Proteinase activated-receptors-associated signaling in the control of gastric cancer 362
Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice 333
The fragile X mental retardation protein regulates RIP1K and colorectal cancer resistance to necroptosis 261
Neutrophil extracellulartraps sustain inflammatory signals in ulcerative colitis 247
Precision Medicine in Inflammatory Bowel Diseases 242
Inflammatory cytokines: from discoveries to therapies in IBD 223
Extent of mucosal inflammation in ulcerative colitis influences the clinical remission induced by vedolizumab 223
Low Frequency of Acute Pancreatitis in Hospitalized COVID-19 Patients 207
Metformin inhibits inflammatory signals in the gut by controlling AMPK and p38 MAP kinase activation 205
A Novel Smad7 Genetic Variant Mapping on the Genomic Region Targeted by Mongersen Is Associated with Crohn's Disease 186
Association between celiac disease and cancer 147
NPD-0414-2 and NPD-0414-24, two chemical entities designed as aryl hydrocarbon receptor (AHR) ligands, inhibit gut inflammatory signals 138
GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation 136
High frequency of undiagnosed psychiatric disorders in inflammatory bowel diseases 133
A pharmacological batch of Mongersen that downregulates Smad7 is effective as induction therapy in active Crohn's disease: a phase II, open-label study 132
Novel therapeutic options for people with ulcerative colitis: an update on recent developments with Janus Kinase (JAK) inhibitors 124
An essential role of adenosine deaminase acting on RNA 1 in coeliac disease mucosa 115
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders 108
Involvement of smad7 in inflammatory diseases of the gut and colon cancer 101
The Deubiquitinating Enzyme OTUD5 Sustains Inflammatory Cytokine Response in Inflammatory Bowel Disease 98
Low frequency of COVID-19 in inflammatory bowel diseases 92
Effect of Vedolizumab on anemia of chronic disease in patients with inflammatory bowel diseases 91
Preventable predictive factors of post-colonoscopy colorectal cancer in inflammatory bowel disease 86
Niclosamide enema for active distal ulcerative colitis: a phase I, open-label study 83
Transforming Growth Factor-β1/Smad7 in Intestinal Immunity, Inflammation, and Cancer 76
Low prevalence of SARS-CoV-2 infection in inflammatory bowel disease 76
Inhomogeneous Diastereomeric Composition of Mongersen Antisense Phosphorothioate Oligonucleotide Preparations and Related Pharmacological Activity Impairment 76
Immune-mediated inflammatory diseases: Common and different pathogenic and clinical features 75
Metalloproteinases in inflammatory bowel diseases 73
Respiratory Tract Infections in Inflammatory Bowel Disease Patients Taking Vedolizumab: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 72
Loss of Adenosine Deaminase Acting on RNA 1 Induces Panoptosis and Immune Response in Ulcerative Colitis Gut Mucosa 70
Interleukin-34 promotes tumorigenic signals for colon cancer cells 70
Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms 68
Frequency and Predictors of Dysplasia in Pseudopolyp-like Colorectal Lesions in Patients with Long-Standing Inflammatory Bowel Disease 65
Long-Term Risk of Colectomy in Patients with Severe Ulcerative Colitis Responding to Intravenous Corticosteroids or Infliximab 64
Endoscopic Predictors of Neoplastic Lesions in Inflammatory Bowel Diseases Patients Undergoing Chromoendoscopy 61
Role of TGF-Beta and Smad7 in Gut Inflammation, Fibrosis and Cancer 58
Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease 58
Reversibility of Frail Phenotype in Patients with Inflammatory Bowel Diseases 58
No effect of a liquid diet in the management of patients with stricturing Crohn’s disease 57
Best of UEG Week 2024 56
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation 56
Severe acute respiratory syndrome coronavirus 2 infection does not worsen the course of inflammatory bowel disease in the long term 53
Natural History of Ulcerative Colitis with Coexistent Colonic Diverticulosis. 53
Long-term outcomes and predictive factors of hospitalized patients with severe ulcerative colitis treated with intravenous corticosteroids 53
Paradoxical hidradenitis suppurativa in Crohn's disease patients receiving infliximab: a case report and review of literature 52
Smoking and colorectal cancer in inflammatory bowel disease: Quantity matters? 49
Gut microbiota analysis in inflammatory bowel disease: Novel findings from old data 49
Smad7 Antisense Oligonucleotide-Based Therapy in Crohn's Disease: Is it Time to Re-Evaluate? 49
Vedolizumab and new‐onset spondyloarthritis: Debunking the myth 43
Knockdown of Smad7 With a Specific Antisense Oligonucleotide Attenuates Colitis and Colitis-Driven Colonic Fibrosis in Mice 40
Oligonucleotide-Based Therapies for Inflammatory Bowel Disease 37
Quality of clinical guidelines: It matters as it impacts patient care 34
Frequency of dysplasia in endoscopically resected pseudopolyps in inflammatory bowel diseases 34
High Smad7 marks inflammation in patients with chronic pouchitis 33
Treatment options for refractory ulcerative colitis: Small molecules, big effects 31
Clinical outcome after entero-enteric anastomosis for Crohn’s disease: a case-control study 31
Inflammatory Bowel Disease Patients with a History of Cancer: Safety of Immunomodulators in a Multicenter Study 26
Inhibiting Oxidative Phosphorylation In Vivo Restrains Th17 Effector Responses and Ameliorates Murine Colitis 25
Inflammatory bowel disease: new therapies from antisense oligonucleotides 24
Protective Effects of Aryl Hydrocarbon Receptor Signaling in Celiac Disease Mucosa and in Poly I:C-Induced Small Intestinal Atrophy Mouse Model 15
null 14
Reduced Taurine Serum Levels in Inflammatory Bowel Disease 10
A Contagious Cause of Rectal Bleeding: Misleading Presentation of Chlamydia trachomatis Infection 9
Development and validation of the IBD frailty score in a multicenter prospective cohort of IBD outpatients 9
Understanding Frailty in IBD: Implications for Clinical Outcomes and Multidisciplinary Care 9
Optimizing Drug Positioning in IBD: Clinical Predictors, Biomarkers, and Practical Approaches to Personalized Therapy 7
Molecular Insights into Helicobacter pylori-Induced Gastritis and Gastric Cancer 7
Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease 7
Redox Modulation in Hepatic Fibrosis: Translating NOX1/4 Inhibition to Therapy 7
CD19 CAR T-Cell Therapy for Refractory Ulcerative Colitis 7
Advances in endoscopy in IBD diagnostics and management 6
Totale 18.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.363
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.363
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 78 36
2021/2022610 35 24 23 29 8 45 24 18 139 64 55 146
2022/2023665 65 77 16 85 60 151 62 34 48 21 29 17
2023/2024283 33 5 13 7 20 48 23 53 5 5 17 54
2024/20252.428 34 399 332 131 52 241 132 82 195 215 364 251
2025/20263.655 311 159 386 274 350 191 565 409 445 358 207 0
Totale 18.755